Lilly to Integrate Dexcom CGM into Personalized Diabetes Management System
Go back to Lilly to Integrate Dexcom CGM into Personalized Diabetes Management System| DexCom, Inc. (NASDAQ: DXCM) | Delayed: 68.10 -2.59 (3.66%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $70.69 | 52 Week High | $96.38 | |||
| Open | $69.72 | 52 Week Low | $47.92 | |||
| Day High | $69.86 | P/E | N/A | |||
| Day Low | $67.64 | EPS | $-0.42 | |||
| Volume | 3,930,661 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 990.33 +7.07 (0.72%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $983.26 | 52 Week High | $88.16 | |||
| Open | $975.00 | 52 Week Low | $67.88 | |||
| Day High | $991.22 | P/E | 229.24 | |||
| Day Low | $966.09 | EPS | $4.32 | |||
| Volume | 2,627,108 | |||||
